MedTrace Logo

A Neurofeedback Treatment for Chronic Musculoskeletal Pain

NCT03863847 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2019-03-05

No results posted yet for this study

Summary

This study evaluates the effects of a novel neurofeedback treatment on pain specific brainwaves in adults.

Chronic pain patients enrolled in this study will be randomized into a treatment group and a sham group.

Conditions

Interventions

PROCEDURE

Neurofeedback

The patients will receive neurofeedback on pain related brain-activity, and through training, learn to control said brain-activity.

PROCEDURE

Sham

The patients will receive sham neurofeedback on non-pain related brain-activity, and through training, learn to control said brain-activity.

Sponsors & Collaborators

  • Aalborg University

    lead OTHER

Principal Investigators

  • Natalie Mrachacz Kersting, Dr · Aalborg University, Department of Health Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03863847 on ClinicalTrials.gov